Eric Krauland

2.0k total citations · 1 hit paper
12 papers, 1.2k citations indexed

About

Eric Krauland is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomaterials. According to data from OpenAlex, Eric Krauland has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Biomaterials. Recurrent topics in Eric Krauland's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Diatoms and Algae Research (4 papers) and Molecular Junctions and Nanostructures (3 papers). Eric Krauland is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Diatoms and Algae Research (4 papers) and Molecular Junctions and Nanostructures (3 papers). Eric Krauland collaborates with scholars based in United States. Eric Krauland's co-authors include K. Dane Wittrup, Angela M. Belcher, Beau R. Peelle, Justin Hanes, Maximiliano Vásquez, Jennifer Fiegel, Jie Fu, Tushar Jain, Yingda Xu and Denis Wirtz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, ACS Nano and Biomaterials.

In The Last Decade

Eric Krauland

12 papers receiving 1.1k citations

Hit Papers

Biophysical properties of the clinical-stage antibody lan... 2017 2026 2020 2023 2017 100 200 300 400

Peers

Eric Krauland
Tarik A. Khan Switzerland
Mary J. Cloninger United States
Jared S. Bee United States
Thomas Schluep United States
Raymond S. Tu United States
Zhaohua Huang United States
Eric Krauland
Citations per year, relative to Eric Krauland Eric Krauland (= 1×) peers Christopher B. Howard

Countries citing papers authored by Eric Krauland

Since Specialization
Citations

This map shows the geographic impact of Eric Krauland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Krauland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Krauland more than expected).

Fields of papers citing papers by Eric Krauland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Krauland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Krauland. The network helps show where Eric Krauland may publish in the future.

Co-authorship network of co-authors of Eric Krauland

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Krauland. A scholar is included among the top collaborators of Eric Krauland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Krauland. Eric Krauland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Pejchal, Robert, Anthony B. Cooper, Michael E. Brown, Maximiliano Vásquez, & Eric Krauland. (2023). Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing Variants. Antibodies. 12(3). 54–54. 8 indexed citations
2.
Liu, Catherine Y., Cory L. Ahonen, Michael E. Brown, et al.. (2023). Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity. mAbs. 15(1). 2189974–2189974. 12 indexed citations
3.
Schmidt, Peter, Kristin Narayan, Yong Li, et al.. (2023). Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science Translational Medicine. 15(688). eadg2783–eadg2783. 12 indexed citations
4.
Vásquez, Maximiliano, et al.. (2019). Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed in silico. mAbs. 11(5). 803–808. 5 indexed citations
5.
Jain, Tushar, Tingwan Sun, Stéphanie Durand, et al.. (2017). Biophysical properties of the clinical-stage antibody landscape. Proceedings of the National Academy of Sciences. 114(5). 944–949. 412 indexed citations breakdown →
6.
Xu, Yingda, William P. Roach, Tushar Jain, et al.. (2013). Addressing polyspecificity of antibodies selected from an in vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool. Protein Engineering Design and Selection. 26(10). 663–670. 119 indexed citations
7.
Nam, Ki Tae, et al.. (2008). Peptide-Mediated Reduction of Silver Ions on Engineered Biological Scaffolds. ACS Nano. 2(7). 1480–1486. 134 indexed citations
8.
Krauland, Eric, Beau R. Peelle, K. Dane Wittrup, & Angela M. Belcher. (2007). Peptide tags for enhanced cellular and protein adhesion to single‐crystalline sapphire. Biotechnology and Bioengineering. 97(5). 1009–1020. 50 indexed citations
9.
Peelle, Beau R., Eric Krauland, K. Dane Wittrup, & Angela M. Belcher. (2005). Probing the interface between biomolecules and inorganic materials using yeast surface display and genetic engineering. Acta Biomaterialia. 1(2). 145–154. 43 indexed citations
10.
Peelle, Beau R., Eric Krauland, K. Dane Wittrup, & Angela M. Belcher. (2005). Design Criteria for Engineering Inorganic Material- Specific Peptides. Langmuir. 21(15). 6929–6933. 180 indexed citations
11.
Dawson, Michelle, Eric Krauland, Denis Wirtz, & Justin Hanes. (2004). Transport of Polymeric Nanoparticle Gene Carriers in Gastric Mucus. Biotechnology Progress. 20(3). 851–857. 116 indexed citations
12.
Fu, Jie, Jennifer Fiegel, Eric Krauland, & Justin Hanes. (2002). New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials. 23(22). 4425–4433. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026